Skip to content

Embecta Corp. EMBC Common Stock, Shares, Outstanding

Common Stock, Shares, Outstanding at other companies

Tandem Diabetes Care logo
Tandem Diabetes CareTNDM
Medtronic logo
MedtronicMDT
Lifecore Biomedical, Inc. logo
Lifecore Biomedical, Inc.LFCR
ICU Medical logo
ICU MedicalICUI
Halozyme Therapeutics logo
Halozyme TherapeuticsHALO

Other financials

Income statement

See full
Revenue$221.8M-14.4%
Gross profit$127.8M-22.1%
Operating income$35.0M-44.4%
Net income-$4.1M-117%
EPS (diluted)-$0.07-118%

Balance sheet

See full
Cash & equivalents$193.4M-8.9%
Total debt$1.4B-12.5%
Total equity-$626.1M+15.0%
Total assets$1.0B-8.1%

Cash flow

See full
Operating cash flow$31.1M-2.2%
CapEx$500.0K+400%
Free cash flow$30.6M-3.5%

Valuation

See full
Market cap$193.41M-64.3%
Enterprise value$1.37B-24.8%
P/E1.7×-4.8×
P/S0.2×-0.3×

Profitability

See full
Gross margin61.9%-1.6pp
Operating margin25.8%+9.7pp
Net margin10.7%+5.8pp
FCF margin19.6%+16.0pp

Returns & leverage

See full
Return on equity71.9%
Debt / equity
Current ratio2.5×0.0×

Where this comes from

Reported directly by Embecta Corp. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesOutstanding.

The official record: Embecta Corp.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Embecta Corp.'s common stock, shares, outstanding.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Embecta Corp.'s common stock, shares, outstanding?
Embecta Corp. (EMBC) reported common stock, shares, outstanding of $59.33M in Q1 2026.
How has Embecta Corp.'s common stock, shares, outstanding changed year-over-year?
Embecta Corp.'s common stock, shares, outstanding increased by 1.7% year-over-year, from $58.33M to $59.33M.
What is the long-term trend for Embecta Corp.'s common stock, shares, outstanding?
Over 3 years (2022 to 2025), Embecta Corp.'s common stock, shares, outstanding has grown at a 0.8% compound annual growth rate (CAGR), from $57.06M to $58.5M.